THURSDAY, Sept. 24, 2020 (HealthDay News) — Children who need to take oral steroids for chronic or life-threatening conditions can experience serious side effects, according to new research. Children with autoimmune disorders such as juvenile arthritis, psoriasis or inflammatory bowel disease are often prescribed a steroid to keep the illnessContinue Reading

WEDNESDAY, Sept. 16, 2020 (HealthDay News) — A drug long used to treat Parkinson’s disease may benefit patients with a severe form of age-related macular degeneration (AMD), a small clinical trial suggests. One of the leading causes of vision loss in older people is a condition called dry macular degeneration.Continue Reading

FRIDAY, Sept. 4, 2020 (HealthDay News) — People with lupus aren’t at increased risk of hospitalization from COVID-19 due to steroidal medications they take to reduce immune system activity, a new study finds. And a related study found that people with inflammatory forms of arthritis — such as rheumatoid arthritisContinue Reading

WEDNESDAY, July 1, 2020 (HealthDay News) — A blood test may predict which COVID-19 patients are likely to need a ventilator. This finding could lead to a scoring system that would flag at-risk patients for closer monitoring and to personalized treatments. It may also help explain how diabetes makes outcomesContinue Reading

WEDNESDAY, June 24, 2020 (HealthDay News) — There’s new evidence that a 2,000-year-old medicine might offer hope against a modern scourge: COVID-19. The medication, called colchicine, is an anti-inflammatory taken as a pill. It’s long been prescribed for gout, a form of arthritis, and its history goes back centuries. TheContinue Reading

WEDNESDAY, May 27, 2020 (HealthDay News) — Mindfulness training may help counter the thinking and emotional difficulties caused by multiple sclerosis. In a small test study, people with multiple sclerosis (MS) who had four weeks of mindfulness training emerged with better emotional control and faster thinking. Multiple sclerosis is aContinue Reading

FRIDAY, May 1, 2020 (HealthDay News) — The severity of COVID-19 illness may be influenced by what researchers call “cytokine storms.” In a new study, investigators assessed 522 COVID-19 patients, aged 5 days to 97 years, who were admitted to two hospitals in Wuhan, China, in December and January. TheContinue Reading

SATURDAY, April 25, 2020 (HealthDay News) — Hydroxychloroquine is a key therapy for the autoimmune disease lupus, but interest in it as a potential COVID-19 treatment could make it hard for lupus patients to obtain, experts warn. Hydroxychloroquine is the only medication known to increase survival in patients with systemicContinue Reading

TUESDAY, April 21, 2020 (HealthDay News) — One of the few bright spots in the COVID-19 pandemic has been the perception that children are mostly spared from its worst effects. But what about kids already at risk of contracting serious infections due to a compromised immune system? Do they haveContinue Reading